Cartier Iron Completes Financing; Big Easy Property Drilling to Commence Next Week

Cartier Iron Corporation (CSE: CFE) (“Cartier Iron”) is pleased to announce that it has completed a previously announced non-brokered private placement (the “Private Placement”) of 2,000,000 flow-through units of Cartier Iron at a price of $0.10 per unit (“F-T Units”) for proceeds of $200,000 and 5,000,000 non-flow-through units of Cartier Iron at a price of $0.08 per unit (“Units”) for additional proceeds of $400,000.[...] read more

Enforcer Gold and SOQUEM Announce Amended & Restated Mineral Resource Estimate for the Roger Project Containing 333,000 Gold Eq Ounces Indicated and 202,000 Gold Eq Ounces Inferred

V.VEIN, Enforcer Gold, gold, Quebec, Steve Roebuck

Enforcer Gold Corp (“Enforcer” or the “Company”) (TSX-V: VEIN; FSE: N071) along with SOQUEM today announce the results of an amended and restated mineral resource estimate on the Mop-II gold-copper deposit at the Company’s Roger project. Enforcer is earning a 50% interest in the Roger project from project operator, SOQUEM. [...] read more

Cartier Confirms Mineralization Continuity to a Depth of 1.6 km at Chimo Mine

Cartier Resources

Cartier Resources Inc. (TSX-V: ECR) (“Cartier” or the Corporation) announces that it now has data which confirm the presence of gold mineralization within 20 drill holes completed between 1.0 and 1.6 km at the Chimo Mine project, located 45 km east of Val-d’Or. All holes intersected gold mineralization similar to that at Chimo Mine, to which are added the following new results: 4.7 g / t Au over 5.0 m included within 1.8 g / t Au over 16.6 m and 3.6 g / t Au over 4.0 m included 1.3 g / t Au over 17.4 m (FIGURE).[...] read more

FSD Pharma Announces Upgraded Listing to OTCQB Venture Market

C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (FRA: 0K9) announced today that its subordinate voting shares have been upgraded to a listing on the OTCQB (“OTCQB”) Venture Market, trading under the ticker symbol “FSDDF.” The Company’s subordinate voting shares continue to be listed on the Canadian Stock Exchange (“CSE”) under the ticker symbol “HUGE” and on the Frankfurt Stock Exchange (“FRA”) under the ticker symbol “0K9.” [...] read more

Golden Predator Intercepts 8.5 meters of 5 g/t Gold at Brewery Creek Project; Drilling Extends Known Gold Mineralization over 200 m

Golden Predator, V.GPY, gold, Yukon, Bill Sheriff

Golden Predator Mining Corp. (TSX.V:GPY, OTCQX:NTGSF) (the “Company”) is pleased to announce the successful completion of a 22 hole exploration and metallurgical drilling program at its 100% owned Brewery Creek Project in Canada’s Yukon, and reports today on the results of the exploration drill program designed to expand the current resource.  Significant gold mineralization was encountered in 8 of the 9 exploration holes increasing known gold mineralization around five zones including Schooner, Sleeman, Lucky, Bohemian and Lone Star.[...] read more

Cauchari JV Project Update Further Excellent Phase III Results in NW Sector Holes CAU20 and CAU21 – samples up to 700 mg/l lithium

V.AAL, Advantage Lithium, lithium, Argentina, David Sidoo
Figure 1 – location of CAU20 & CAU21 (CNW Group/Advantage Lithium Corp)

Advantage Lithium Corp. (the “Company” or “Advantage Lithium”) (TSX Venture: AAL) (OTCQX: AVLIF) is pleased to provide this update on the brine sampling of diamond core holes CAU20 and CAU21 in the NW Sector of the Cauchari JV property located in Jujuy Province, Argentina. [...] read more

FSD Pharma signs collaboration and profit sharing agreement with Canntab for production and market of oral dose delivery platforms

C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company), which, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, is pleased to announce that it has signed a definitive collaboration and profit sharing agreement (the “Agreement“) with Canntab Therapeutics Limited (CSE:PILL) (“Canntab“), a leader in the rapidly growing cannabis pill market, effective September 17, 2018. Under the terms of the Agreement, FSD Pharma will assist Canntab to obtain a license to process and sell cannabis products pursuant to the Cannabis Act (the “License“), and will provide Canntab with space at its facility (the “FSD Facility“), which is located just one hour east of Toronto in Cobourg, Ontario (the “Transaction“). [...] read more